Amylin Expands Manufacturing Facility in Ohio
ePT--the Electronic Newsletter of Pharmaceutical Technology
Hamilton, OH (May 2)-Amylin Ohio LLC, a subsidiary of Amylin Pharmaceuticals, is expanding construction at its manufacturing facility in West Chester, Ohio. The expansion increases the company?s total investment to approximately $400 million.
Hamilton, OH (May 2)-Amylin Ohio LLC, a subsidiary of Amylin Pharmaceuticals (San Diego, CA, www.amylin.com), is expanding construction at its manufacturing facility in West Chester, Ohio. The expansion increases the company’s total investment to approximately $400 million.
The manufacturing facility is in the process of being equipped to manufacture the company’s long-acting release formulation of exenatide, which is being developed to treat Type-2 diabetes. The expanded facility is expected to create up to 500 jobs over the next three years.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
